✦ LIBER ✦

Sexual dysfunction and physicians' perception in medicated patients with major depression in Taiwan

✍ Scribed by Kao Ching Chen; Yen Kuang Yang; I Hui Lee; Tzung Lieh Yeh; Ru-Band Lu; Po See Chen

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 96 KB
Volume: 25
Category: Article
ISSN: 1091-4269
DOI: 10.1002/da.20312

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mirtazapine augmentation in depressed pa

Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors

✍ Nahit Kamil Ozmenler; Tunay Karlidere; Ali Bozkurt; Sinan Yetkin; Ali Doruk; Lev 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

## Abstract ## Objective To evaluate the effect of mirtazapine augmentation in patients with sexual dysfunction induced by current selective serotonin reuptake inhibitor (SSRI) treatment. ## Methods Forty‐nine outpatients in remission from major depressive disorder with SSRI treatment and experi

Depression and major depressive disorder

Depression and major depressive disorder in patients with Parkinson's disease

✍ Takeshi Inoue; Mayumi Kitagawa; Teruaki Tanaka; Shin Nakagawa; Tsukasa Koyama 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract The prevalence of depression in Parkinson's disease (PD) varies greatly. In this study, we investigated major depressive disorder (MDD) and depressive symptoms without MDD in patients with PD. The psychopathological characteristics of depressive symptoms were assessed by a psychiatric i

Switching to tianeptine in patients with

Switching to tianeptine in patients with antidepressant-induced sexual dysfunction

✍ Murad Atmaca; Murat Kuloglu; Ertan Tezcan; Ayten Buyukbayram 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

## Abstract Sexual side effects are frequent and are recently being considered as effects of antidepressant treatment. One method to improve the sexual dysfunction associated with the use of antidepressants is to change to another antidepressant. In the present work, the consequences of switching t

The effect of alexithymic features on re

The effect of alexithymic features on response to antidepressant medication in patients with major depression

✍ Aytekin Özsahin; Özcan Uzun; Adnan Cansever; Zeynep Gulcat 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

Comparison of pramipexole, fluoxetine, a

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression

✍ Mark H. Corrigan; Angelita Q. Denahan; C. Eugene Wright; Rhonda J. Ragual; Dwigh 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Pramipexole, a dopamine D 2 receptor agonist, was tested in 174 patients with major depression, with or without melancholia and without psychotic features. Three daily dose levels (0.375 mg, 1.0 mg, and 5.0 mg) were compared to fluoxetine (Prozac) at 20 mg and placebo in a randomized, double-blind,

Antibodies against serotonin and ganglio

Antibodies against serotonin and gangliosides in patients with fibromyalgia and major depression

✍ W. Samborski; A. Sluzewska; J. K. Lacki; M. Sobieska; R. Klein; S. Mackiewicz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Antibodies against serotonin and gangliosides in patients with ®bromyalgia and major depression The ®bromyalgia syndrome (FMS) is a nonarticular disorder associated with disturbances in serotonin (5-HT) metabolism Samborski et al., 1996a,b). Moreover the psychological pro®les of these patients rev